Ontada, Merck Partner to Facilitate Real World Evidence Studies for Cancer Care

August 30, 2021

What You Should Know: Ontada , McKesson’s oncology and insights business, announced a strategic agreement with Merck , known as MSD outside the United States and Canada, that will facilitate the development of real-world research excellence and innovation. This agreement enables the two healthcare leaders to harness the power of real-world evidence (RWE) towards the common goal of improving patient outcomes and the quality of cancer care.

Read the source article at Healthcare IT News
2021-08-27 22:08:01

Share This Story!